Article Versions Notes

Tobias J, Högler S, Raigel M, Lin DS-C, Chao Y, Kenner L, Garner-Spitzer E, Yavrom S, Ede NJ, Zielinski CC, et al. Preclinical and Clinical Observations Implying Combination Therapy to Enhance the Efficacy of the Her-2/neu B-Cell Peptide-Based Vaccine HER-Vaxx and to Prevent Immune Evasion. International Journal of Molecular Sciences. 2024; 25(1):287. https://doi.org/10.3390/ijms25010287

Tobias, Joshua, Sandra Högler, Martin Raigel, Diego Shih-Chieh Lin, Yee Chao, Lukas Kenner, Erika Garner-Spitzer, Sharon Yavrom, Nicholas J. Ede, Christoph C. Zielinski, and et al. 2024. "Preclinical and Clinical Observations Implying Combination Therapy to Enhance the Efficacy of the Her-2/neu B-Cell Peptide-Based Vaccine HER-Vaxx and to Prevent Immune Evasion" International Journal of Molecular Sciences 25, no. 1: 287. https://doi.org/10.3390/ijms25010287

Tobias, J., Högler, S., Raigel, M., Lin, D. S.-C., Chao, Y., Kenner, L., Garner-Spitzer, E., Yavrom, S., Ede, N. J., Zielinski, C. C., Kundi, M., & Wiedermann, U. (2024). Preclinical and Clinical Observations Implying Combination Therapy to Enhance the Efficacy of the Her-2/neu B-Cell Peptide-Based Vaccine HER-Vaxx and to Prevent Immune Evasion. International Journal of Molecular Sciences, 25(1), 287. https://doi.org/10.3390/ijms25010287